维普中文期刊产品整合服务
252篇 您的检索式:作者名="RIGGS BL"
    题名 作者 年代 出处 被引量
1A bone structural basis for fracture risk in diabetes显示文摘Melton LJ Riggs BL Leibson C 2008J Clin Endocrinol Metab2008,93,:1
2Role of RANK ligand in mediating increased bone resorption in early postmenopausal women显示文摘Eghbali-Fatourechi G Khosla S Sanyal A Boyle WJ Lacey DL Riggs BL 0,,:1
3The worldwide problem of osteoporosis: insights afforded by epidemiology显示文摘Riggs BL Melton LJ 3rd 1995Bone1995,17,5:1
4Effects of raloxifene,a se lective estrogen receptor modulator,on bone turnover markers and se- rum sex steroid and lipid levels in elderly me显示文摘Doran PM Riggs BL Atkinson E J etal 2001J Bone Miner Res2001,16,11:1
5Bone densitometry and clinical decision-making in osteoporosis显示文摘Riggs BL Wahner HW 1988Ann Intern Med1988,108,2:1
6Effects of immuno- suppressants on receptor activator of NF-r,B ligand and osteop- rotegerin production by human osteoblastic and coronary artery smooth muscle cells 显示文摘z Hofoauer LC Shui C Riggs BL 2001Biochem Biophys Res Commun2001,,:1
7Research directions in osteoporosis显示文摘Peck WA Riggs BL Bell NH 1988Am J Med1988,84,2:1
8Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodelin显示文摘RIGGS BL PARFITT AM 2005J Bone Miner Res2005,20,2:1
9Skeletal effects of estrogen显示文摘Turner RT Riggs BL Spelsberg TC 1994Endocr Rev1994,15,3:1
10Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D[1,25-(OH)2D] levels in young versus elderly women:evidence for age-related intestinal resistance to 1,25(OH)2D action显示文摘Pattanaungkul S Riggs BL Yergey AL 0,,11:1
11Osteoclasts and transfoming growth factor heta estrogen mediated isoform-specific regulation of production 显示文摘Bobinson JA Riggs BL Spelsberg TC 1996Endorinot1996,137,2:1
12Production of va-rious cytokines by normal human osteoblast - like cells inresponse to interleukin - 1 beta and tumor necrosis factor -alpha : lack of reglation by 17 beta - estradiol 显示文摘Chaudhary LR Spelsbetg TC Riggs BL 1992Endo cri-nology1992,130,:1
13Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid- induced osteoporosis 显示文摘Hofbauer LC Gori F Riggs BL 1999Endocrinology1999,140,10:1
14Skeletal effects of estrogen 显示文摘Turner RT Riggs BL Spelsberg TC 1994Endocr Rev1994,15,3:1
15Osteoporosis Second edieion显示文摘Riggs BL 1995Ljppinxott-Raren Publishers1995,227,:1
16Changes in Rtmx2/Oofal expression and activity during osteoblastic differentiation of human bone marrow stmmal cells 显示文摘Shui C Spelsberg TC Riggs BL 2003J Bone iVfiner Res2003,18,2:1
17The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: Is a revision needed? 显示文摘Khosla S Melton LJ 3rd Riggs BL 2011] Bone Miner Res2011,26,3:1
18The worldwide problem of osteoporosis: insights afforded by epidemiologist 显示文摘Riggs BL Melton LJ 3rd 1995Bone1995,17,5:1
19Estrogenregulation of human osteoblastic cell proliferation and differentiation 显示文摘Robinson JA Harris SA Riggs BL 2000Endocrinology2000,138,:1
20Development and characterization of a conditionally immortalized human fetal osteoblastic cell line显示文摘Harris SA Enger R J Riggs BL 1995J Bone Miner Res1995,10,2:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费